...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems

"Whatever....  they dropped .13 cents,"

Right after that split, RVX dropped 6x that.

"it could have jumped right back up .13 or more cents the next day , "

It didn't.

"still no out of pocket expense in terms of shares that you had to pay for , "

Not "out of pocket".  Just out of the value of my RVX stock.

 

Share
New Message
Please login to post a reply